Brief: Zivo Bioscience Files For Offering Of 3 Million Shares Of Common Stock Underlying Series A Common Warrants, Series B Common Warrants By Selling Stockholder
28/07/2023 11:19
July 28 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ZIVO BIOSCIENCE FILES FOR OFFERING OF 3 MILLION SHARES OF
COMMON
STOCK UNDERLYING SERIES A COMMON WARRANTS, SERIES B COMMON
WARRANTS BY SELLING STOCKHOLDER
Further company coverage: ZIVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens